| 000 | 01858 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250516233717.0 | ||
| 264 | 0 | _c20151228 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1468-1293 | ||
| 024 | 7 |
_a10.1111/hiv.12197 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGonzalez, F A | |
| 245 | 0 | 0 |
_aLiver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients. _h[electronic resource] |
| 260 |
_bHIV medicine _cApr 2015 |
||
| 300 |
_a211-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 |
_aAspartate Aminotransferases _xmetabolism |
| 650 | 0 | 4 |
_aCoinfection _xcomplications |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aElasticity Imaging Techniques _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aHepatitis C _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xmetabolism |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSpain _xepidemiology |
| 700 | 1 | _aVan den Eynde, E | |
| 700 | 1 | _aPerez-Hoyos, S | |
| 700 | 1 | _aNavarro, J | |
| 700 | 1 | _aCurran, A | |
| 700 | 1 | _aBurgos, J | |
| 700 | 1 | _aFalcó, V | |
| 700 | 1 | _aOcaña, I | |
| 700 | 1 | _aRibera, E | |
| 700 | 1 | _aCrespo, M | |
| 773 | 0 |
_tHIV medicine _gvol. 16 _gno. 4 _gp. 211-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/hiv.12197 _zAvailable from publisher's website |
| 999 |
_c24203469 _d24203469 |
||